RAPID could enable Medicare coverage and payment as soon as two months after FDA approval, compared to a year or more with ...
The US Food and Drug Administration (FDA) has released a new medical device draft guidance intended to assist manufacturers in designing and developing devices used by a patient in their own ...
In the past 18 months, the FDA has outlined clear guidelines for designing, documenting, updating, and monitoring AI-powered ...
The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class ...